MetaADEDB 2.0 @ LMMD
Cabozantinib S-malate
(HFCFMRYTXDINDK-WNQIDUERSA-N)
Structure
SMILES
OC(=O)C[C@@H](C(=O)O)O.COc1cc2c(ccnc2cc1OC)Oc1ccc(cc1)NC(=O)C1(CC1)C(=O)Nc1ccc(cc1)F
Molecular Formula:
C32H30FN3O10
Molecular Weight:
635.593
Log P:
4.5934
Hydrogen Bond Acceptor:
13
Hydrogen Bond Donor:
5
TPSA:
193.61
CAS Number(s):
942407-59-2; 1140909-48-3
Synonym(s)
1.
Cabozantinib S-malate
External Link(s)
PubChem Compound25102846
ChEBI72319
CHEMBLCHEMBL2103868
KEGGdr:D10095
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 466
Canada Vigilance: 2
Canada Vigilance
US FAERS
2NauseaFAERS: 294US FAERS
3Malignant neoplasm progressionFAERS: 230
Canada Vigilance: 2
Canada Vigilance
US FAERS
4StomatitisFAERS: 183
Canada Vigilance: 1
Canada Vigilance
US FAERS
5Weight decreasedFAERS: 173
Canada Vigilance: 1
Canada Vigilance
US FAERS
6VomitingFAERS: 126US FAERS
7AstheniaFAERS: 124US FAERS
8ConstipationFAERS: 121US FAERS
9DysgeusiaFAERS: 107US FAERS
10Oral painFAERS: 105
Canada Vigilance: 1
Canada Vigilance
US FAERS
11DysphoniaFAERS: 97US FAERS
12Skin UlcerFAERS: 92US FAERS
13MalaiseFAERS: 87US FAERS
14Dry skinFAERS: 78US FAERS
15Drug ineffectiveFAERS: 76
Canada Vigilance: 2
Canada Vigilance
US FAERS
16HeadacheFAERS: 70
Canada Vigilance: 1
Canada Vigilance
US FAERS
17DizzinessFAERS: 69
Canada Vigilance: 1
Canada Vigilance
US FAERS
18ErythemaFAERS: 64US FAERS
19ArthralgiaFAERS: 62
Canada Vigilance: 1
Canada Vigilance
US FAERS
20PainFAERS: 62
Canada Vigilance: 1
Canada Vigilance
US FAERS
21DehydrationFAERS: 61
Canada Vigilance: 1
Canada Vigilance
US FAERS
22AlopeciaFAERS: 58US FAERS
23Oropharyngeal painFAERS: 57
Canada Vigilance: 1
Canada Vigilance
US FAERS
24Abdominal discomfortFAERS: 52US FAERS
25PruritusFAERS: 49US FAERS
26Peripheral swellingFAERS: 47US FAERS
27DyspepsiaFAERS: 42US FAERS
28HypothyroidismFAERS: 41US FAERS
29Back PainFAERS: 39US FAERS
30PneumoniaFAERS: 38US FAERS
31AgeusiaFAERS: 37US FAERS
32Abdominal PainFAERS: 35US FAERS
33FlatulenceFAERS: 34US FAERS
34Pulmonary EmbolismFAERS: 33US FAERS
35ThrombosisFAERS: 31US FAERS
36Burning sensationFAERS: 29US FAERS
37MyalgiaFAERS: 29US FAERS
38NasopharyngitisFAERS: 29US FAERS
39Toxicity to various agentsFAERS: 29US FAERS
40EpistaxisFAERS: 25US FAERS
41Urinary tract infectionFAERS: 25US FAERS
42Feeling abnormalFAERS: 24US FAERS
43HyperkeratosisFAERS: 24US FAERS
44LethargyFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
45AcneFAERS: 21US FAERS
46Chest PainFAERS: 21US FAERS
47Bone painFAERS: 20US FAERS
48Memory impairmentFAERS: 20US FAERS
49ProteinuriaFAERS: 20US FAERS
50Adverse eventFAERS: 18US FAERS
51Cerebrovascular accidentFAERS: 18US FAERS
52InfectionFAERS: 18US FAERS
53Tongue discomfortFAERS: 18US FAERS
54Alanine Aminotransferase IncreasedFAERS: 16US FAERS
55AnxietyFAERS: 16US FAERS
56AphoniaFAERS: 16US FAERS
57Blood thyroid stimulating hormone increasedFAERS: 16US FAERS
58Skin lesionFAERS: 16US FAERS
59General physical health deteriorationFAERS: 15US FAERS
60InfluenzaFAERS: 15US FAERS
61Joint swellingFAERS: 15US FAERS
62SinusitisFAERS: 15US FAERS
63Skin irritationFAERS: 15US FAERS
64SomnolenceFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
65HypotensionFAERS: 14US FAERS
66Nasal discomfortFAERS: 14US FAERS
67Pain of skinFAERS: 14US FAERS
68GlossitisFAERS: 13US FAERS
69Myocardial InfarctionFAERS: 13US FAERS
70RetchingFAERS: 13US FAERS
71SepsisFAERS: 13US FAERS
72Skin toxicityFAERS: 13US FAERS
73Blood magnesium decreasedFAERS: 12US FAERS
74GoutFAERS: 12US FAERS
75Throat irritationFAERS: 12US FAERS
76Tongue blisteringFAERS: 12US FAERS
77ToothacheFAERS: 12US FAERS
78White blood cell count decreasedFAERS: 12US FAERS
79AmnesiaFAERS: 11US FAERS
80ChillsFAERS: 11US FAERS
81Depressed moodFAERS: 11US FAERS
82Drug dose omissionFAERS: 11US FAERS
83Intestinal ObstructionFAERS: 11US FAERS
84NeuralgiaFAERS: 11US FAERS
85Ejection Fraction DecreasedFAERS: 10US FAERS
86HepatotoxicityFAERS: 10US FAERS
87Limb discomfortFAERS: 10US FAERS
88SwellingFAERS: 10US FAERS
89ThrombocytopeniaFAERS: 10US FAERS
90TremorFAERS: 10US FAERS
91Visual ImpairmentFAERS: 10US FAERS
92Blood sodium decreasedFAERS: 9US FAERS
93Disease ProgressionFAERS: 9US FAERS
94Lower respiratory tract infectionFAERS: 9US FAERS
95Mouth swellingFAERS: 9US FAERS
96Productive CoughFAERS: 9US FAERS
97Transaminases increasedFAERS: 9US FAERS
98Wrong technique in product usage processFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
99Acute kidney injuryFAERS: 8US FAERS
100Feeling ColdFAERS: 8US FAERS
101Genital rashFAERS: 8US FAERS
102InflammationFAERS: 8US FAERS
103UlcerFAERS: 8US FAERS
104Blood creatinine increasedFAERS: 7US FAERS
105Blood potassium decreasedFAERS: 7US FAERS
106Blood potassium increasedFAERS: 7US FAERS
107Blood pressure fluctuationFAERS: 7US FAERS
108Blood urine presentFAERS: 7US FAERS
109DiscomfortFAERS: 7US FAERS
110DisorientationFAERS: 7US FAERS
111HypersomniaFAERS: 7US FAERS
112HyperthyroidismFAERS: 7US FAERS
113Musculoskeletal stiffnessFAERS: 7US FAERS
114Product dose omissionFAERS: 7US FAERS
115Therapy cessationFAERS: 7US FAERS
116ArthropathyFAERS: 6US FAERS
117Aspartate Aminotransferase IncreasedFAERS: 6US FAERS
118Blood alkaline phosphatase increasedFAERS: 6US FAERS
119Blood glucose decreasedFAERS: 6US FAERS
120CataractFAERS: 6US FAERS
121ColitisFAERS: 6US FAERS
122DysuriaFAERS: 6US FAERS
123Gastric ulcerFAERS: 6US FAERS
124Gastrointestinal perforationFAERS: 6US FAERS
125Large intestine perforationFAERS: 6US FAERS
126Musculoskeletal PainFAERS: 6US FAERS
127Night sweatsFAERS: 6US FAERS
128Osteonecrosis of JawFAERS: 6US FAERS
129Performance status decreasedFAERS: 6US FAERS
130Skin reactionFAERS: 6US FAERS
131Therapeutic response unexpectedFAERS: 6US FAERS
132Anorectal discomfortFAERS: 5US FAERS
133Blood cholesterol increasedFAERS: 5US FAERS
134Blood glucose increasedFAERS: 5US FAERS
135BronchitisFAERS: 5US FAERS
136Cancer PainFAERS: 5US FAERS
137CheilitisFAERS: 5US FAERS
138ChromaturiaFAERS: 5US FAERS
139Cold sweatFAERS: 5US FAERS
140DermatitisFAERS: 5US FAERS
141DiverticulitisFAERS: 5US FAERS
142FlushingFAERS: 5US FAERS
143Gait inabilityFAERS: 5US FAERS
144Hospice CareFAERS: 5US FAERS
145LymphadenopathyFAERS: 5US FAERS
146OsteomyelitisFAERS: 5US FAERS
147PancreatitisFAERS: 5US FAERS
148Secretion dischargeFAERS: 5US FAERS
149StressFAERS: 5US FAERS
150TachycardiaFAERS: 5US FAERS
151Therapy changeFAERS: 5US FAERS
152Wound InfectionFAERS: 5US FAERS
153Acute myocardial infarctionFAERS: 4US FAERS
154ArthritisFAERS: 4US FAERS
155Atrial FibrillationFAERS: 4US FAERS
156Chest discomfortFAERS: 4US FAERS
157CholecystitisFAERS: 4US FAERS
158Clostridium difficile infectionFAERS: 4US FAERS
159CystitisFAERS: 4US FAERS
160Deep Vein ThrombosisFAERS: 4US FAERS
161Electrolyte imbalanceFAERS: 4US FAERS
162EructationFAERS: 4US FAERS
163Facial PainFAERS: 4US FAERS
164Gastrointestinal toxicityFAERS: 4US FAERS
165HypersensitivityFAERS: 4US FAERS
166Incorrect dose administeredFAERS: 4US FAERS
167Intestinal PerforationFAERS: 4US FAERS
168Limb injuryFAERS: 4US FAERS
169Loss of personal independence in daily activitiesFAERS: 4US FAERS
170Musculoskeletal discomfortFAERS: 4US FAERS
171NeutropeniaFAERS: 4US FAERS
172OnychalgiaFAERS: 4US FAERS
173PalpitationsFAERS: 4US FAERS
174Pathological fractureFAERS: 4US FAERS
175PhotophobiaFAERS: 4US FAERS
176Posterior reversible encephalopathy syndromeFAERS: 4US FAERS
177Respiratory FailureFAERS: 4US FAERS
178ScabFAERS: 4US FAERS
179Skin ErosionFAERS: 4US FAERS
180SluggishnessFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
181Upper-airway cough syndromeFAERS: 4US FAERS
182Urinary RetentionFAERS: 4US FAERS
183Wound dehiscenceFAERS: 4US FAERS
184skin abrasionFAERS: 4US FAERS
185Acute respiratory failureFAERS: 3US FAERS
186Anal FistulaFAERS: 3US FAERS
187Arthropod biteFAERS: 3US FAERS
188Back disorderFAERS: 3US FAERS
189Blood count abnormalFAERS: 3US FAERS
190Blood lactate dehydrogenase increasedFAERS: 3US FAERS
191Blood urea increasedFAERS: 3US FAERS
192Cardiac ArrestFAERS: 3US FAERS
193CholestasisFAERS: 3US FAERS
194Coronary Artery DiseaseFAERS: 3US FAERS
195Dental cariesFAERS: 3US FAERS
196Drug dispensing errorFAERS: 3US FAERS
197Ear discomfortFAERS: 3US FAERS
198Emotional distressFAERS: 3US FAERS
199EpilepsyFAERS: 3US FAERS
200Exfoliative rashFAERS: 3US FAERS
201Failure to ThriveFAERS: 3US FAERS
202GastroenteritisFAERS: 3US FAERS
203Gastrointestinal stoma complicationFAERS: 3US FAERS
204Head discomfortFAERS: 3US FAERS
205HepatitisFAERS: 3US FAERS
206HypogeusiaFAERS: 3US FAERS
207HypophagiaFAERS: 3US FAERS
208Infrequent bowel movementsFAERS: 3US FAERS
209Joint stiffnessFAERS: 3US FAERS
210Neck PainFAERS: 3US FAERS
211NervousnessFAERS: 3US FAERS
212No adverse eventFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
213Oral candidiasisFAERS: 3US FAERS
214Oral mucosal eruptionFAERS: 3US FAERS
215OverdoseFAERS: 3US FAERS
216PallorFAERS: 3US FAERS
217Perianal erythemaFAERS: 3US FAERS
218Plantar erythemaFAERS: 3US FAERS
219Poor peripheral circulationFAERS: 3US FAERS
220RhinitisFAERS: 3US FAERS
221SyncopeFAERS: 3US FAERS
222Thermal burnFAERS: 3US FAERS
223Thyroid hormones increasedFAERS: 3US FAERS
224ThyroiditisFAERS: 3US FAERS
225Tooth InfectionFAERS: 3US FAERS
226Wrong doseFAERS: 3US FAERS
227AgitationFAERS: 2US FAERS
228AngioedemaFAERS: 2US FAERS
229Anorectal infectionFAERS: 2US FAERS
230Aortic AneurysmFAERS: 2US FAERS
231AphasiaFAERS: 2US FAERS
232AscitesFAERS: 2US FAERS
233Benign Prostatic HyperplasiaFAERS: 2US FAERS
234BlindnessFAERS: 2US FAERS
235Blood albumin abnormalFAERS: 2US FAERS
236Blood glucose abnormalFAERS: 2US FAERS
237Blood sodium increasedFAERS: 2US FAERS
238Bone lesionFAERS: 2US FAERS
239Cataract operationFAERS: 2US FAERS
240ChokingFAERS: 2US FAERS
241CholelithiasisFAERS: 2US FAERS
242Clostridium difficile colitisFAERS: 2US FAERS
243CystFAERS: 2US FAERS
244Dental cleaningFAERS: 2US FAERS
245Device occlusionFAERS: 2US FAERS
246Diabetes MellitusFAERS: 2US FAERS
247Drug administration errorFAERS: 2US FAERS
248Drug ineffective for unapproved indicationFAERS: 2US FAERS
249DysarthriaFAERS: 2US FAERS
250EmbolismFAERS: 2US FAERS
251Endodontic procedureFAERS: 2US FAERS
252Escherichia sepsisFAERS: 2US FAERS
253Exposed bone in jawFAERS: 2US FAERS
254Facial paralysisFAERS: 2US FAERS
255Feeling jitteryFAERS: 2US FAERS
256Fistula of small intestineFAERS: 2US FAERS
257Flank PainFAERS: 2US FAERS
258Frustration tolerance decreasedFAERS: 2US FAERS
259Full blood count abnormalFAERS: 2US FAERS
260Full blood count decreasedFAERS: 2US FAERS
261Gamma-Glutamyltransferase IncreasedFAERS: 2US FAERS
262Gastrointestinal PainFAERS: 2US FAERS
263Gastrointestinal infectionFAERS: 2US FAERS
264General physical condition abnormalFAERS: 2US FAERS
265GingivitisFAERS: 2US FAERS
266Hepatic EncephalopathyFAERS: 2US FAERS
267HyperchlorhydriaFAERS: 2US FAERS
268HypertransaminasaemiaFAERS: 2US FAERS
269HyperventilationFAERS: 2US FAERS
270HypokinesiaFAERS: 2US FAERS
271HypopituitarismFAERS: 2US FAERS
272HypoxiaFAERS: 2US FAERS
273Increased tendency to bruiseFAERS: 2US FAERS
274Infected seromaFAERS: 2US FAERS
275Liver AbscessFAERS: 2US FAERS
276LymphopeniaFAERS: 2US FAERS
277Mastication disorderFAERS: 2US FAERS
278Mental impairmentFAERS: 2US FAERS
279Mental status changesFAERS: 2US FAERS
280Muscle FatigueFAERS: 2US FAERS
281Musculoskeletal chest painFAERS: 2US FAERS
282Nail InfectionFAERS: 2US FAERS
283Nasal mucosal disorderFAERS: 2US FAERS
284NephrolithiasisFAERS: 2US FAERS
285Nephrotic SyndromeFAERS: 2US FAERS
286Nerve injuryFAERS: 2US FAERS
287NocturiaFAERS: 2US FAERS
288Non-cardiac chest painFAERS: 2US FAERS
289OsteoporosisFAERS: 2US FAERS
290Pelvic PainFAERS: 2US FAERS
291Penile burning sensationFAERS: 2US FAERS
292PharyngitisFAERS: 2US FAERS
293PneumothoraxFAERS: 2US FAERS
294Poor personal hygieneFAERS: 2US FAERS
295Postoperative wound complicationFAERS: 2US FAERS
296Procedural intestinal perforationFAERS: 2US FAERS
297Radiation PneumonitisFAERS: 2US FAERS
298RadiculopathyFAERS: 2US FAERS
299RegurgitationFAERS: 2US FAERS
300Renal painFAERS: 2US FAERS
301RestlessnessFAERS: 2US FAERS
302Scrotal irritationFAERS: 2US FAERS
303Septic ShockFAERS: 2US FAERS
304Skin discomfortFAERS: 2US FAERS
305Skin hypertrophyFAERS: 2US FAERS
306Spinal column injuryFAERS: 2US FAERS
307Temperature intoleranceFAERS: 2US FAERS
308TetanyFAERS: 2US FAERS
309Thirst decreasedFAERS: 2US FAERS
310ThirstFAERS: 2US FAERS
311Thyroglobulin increasedFAERS: 2US FAERS
312Tinea crurisFAERS: 2US FAERS
313TinnitusFAERS: 2US FAERS
314Tongue erythemaFAERS: 2US FAERS
315Tooth LossFAERS: 2US FAERS
316Umbilical herniaFAERS: 2US FAERS
317Urine output increasedFAERS: 2US FAERS
318Vertebral lesionFAERS: 2US FAERS
319Vitamin D DeficiencyFAERS: 2US FAERS
320Wheelchair userFAERS: 2US FAERS
321WheezingFAERS: 2US FAERS
322XerosisFAERS: 2US FAERS
323jaundiceFAERS: 2US FAERS
324AbasiaFAERS: 1US FAERS
325Abdominal AbscessFAERS: 1US FAERS
326AbscessFAERS: 1US FAERS
327Accidental overdoseFAERS: 1US FAERS
328Adrenal cortex necrosisFAERS: 1US FAERS
329Adrenal thrombosisFAERS: 1US FAERS
330Alanine aminotransferase abnormalFAERS: 1US FAERS
331AlbinismFAERS: 1US FAERS
332Altered state of consciousnessFAERS: 1US FAERS
333Ammonia increasedFAERS: 1US FAERS
334Anal UlcerFAERS: 1US FAERS
335Anal inflammationFAERS: 1US FAERS
336Anal polypFAERS: 1US FAERS
337AngerFAERS: 1US FAERS
338Anorectal swellingFAERS: 1US FAERS
339AnosmiaFAERS: 1US FAERS
340ApathyFAERS: 1US FAERS
341AppendicitisFAERS: 1US FAERS
342Arterial thrombosisFAERS: 1US FAERS
343Basal cell carcinomaFAERS: 1US FAERS
344BedriddenFAERS: 1US FAERS
345Bladder painFAERS: 1US FAERS
346Blood albumin decreasedFAERS: 1US FAERS
347Blood bilirubin unconjugated increasedFAERS: 1US FAERS
348Blood iron increasedFAERS: 1US FAERS
349Blood thyroid stimulating hormone abnormalFAERS: 1US FAERS
350Blood triglycerides increasedFAERS: 1US FAERS
351Bowel movement irregularityFAERS: 1US FAERS
352BradycardiaFAERS: 1US FAERS
353Brain DeathFAERS: 1US FAERS
354Bronchopulmonary AspergillosisFAERS: 1US FAERS
355BruxismFAERS: 1US FAERS
356Cell DeathFAERS: 1US FAERS
357CellulitisFAERS: 1US FAERS
358Central nervous system lesionFAERS: 1US FAERS
359Cerebral ventricle dilatationFAERS: 1US FAERS
360Cerebrospinal fluid circulation disorderFAERS: 1US FAERS
361Chronic Fatigue SyndromeFAERS: 1US FAERS
362Complication associated with deviceFAERS: 1US FAERS
363Creatinine renal clearance decreasedFAERS: 1US FAERS
364DementiaFAERS: 1US FAERS
365Depressed Level of ConsciousnessFAERS: 1US FAERS
366Diabetic KetoacidosisFAERS: 1US FAERS
367DiplopiaFAERS: 1US FAERS
368Disseminated Intravascular CoagulationFAERS: 1US FAERS
369Drug ToleranceFAERS: 1US FAERS
370Drug effect incompleteFAERS: 1US FAERS
371Duodenal UlcerFAERS: 1US FAERS
372DysenteryFAERS: 1US FAERS
373Eastern Cooperative Oncology Group performance status improvedFAERS: 1US FAERS
374EczemaFAERS: 1US FAERS
375Electrocardiogram abnormalFAERS: 1US FAERS
376EncephalitisFAERS: 1US FAERS
377EnteritisFAERS: 1US FAERS
378EosinophiliaFAERS: 1US FAERS
379Erythema MultiformeFAERS: 1US FAERS
380Exposure via body fluidFAERS: 1US FAERS
381Eye irritationFAERS: 1US FAERS
382Eye painFAERS: 1US FAERS
383Eye ulcerFAERS: 1US FAERS
384Eyelid painFAERS: 1US FAERS
385Eyelid rashFAERS: 1US FAERS
386FractureFAERS: 1US FAERS
387Full blood count increasedFAERS: 1US FAERS
388Gastrointestinal inflammationFAERS: 1US FAERS
389Gastrointestinal motility disorderFAERS: 1US FAERS
390Gastrointestinal ulcerFAERS: 1US FAERS
391Gastropleural fistulaFAERS: 1US FAERS
392Gastrostomy tube site complicationFAERS: 1US FAERS
393Genital burning sensationFAERS: 1US FAERS
394Genital painFAERS: 1US FAERS
395Gingival blisterFAERS: 1US FAERS
396GlaucomaFAERS: 1US FAERS
397HemiparesisFAERS: 1US FAERS
398HerniaFAERS: 1US FAERS
399HidradenitisFAERS: 1US FAERS
400HypercreatininaemiaFAERS: 1US FAERS
401HyperpyrexiaFAERS: 1US FAERS
402Hypertensive crisisFAERS: 1US FAERS
403HypocapniaFAERS: 1US FAERS
404HypoperfusionFAERS: 1US FAERS
405IleusFAERS: 1US FAERS
406Impaired quality of lifeFAERS: 1US FAERS
407Inappropriate schedule of product administrationFAERS: 1US FAERS
408IncoherentFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
409Infected cystFAERS: 1US FAERS
410Intentional product use issueFAERS: 1US FAERS
411IntertrigoFAERS: 1US FAERS
412Intervertebral disc disorderFAERS: 1US FAERS
413Intra-abdominal fluid collectionFAERS: 1US FAERS
414Intrathecal pump insertionFAERS: 1US FAERS
415Joint Range of Motion DecreasedFAERS: 1US FAERS
416LaryngitisFAERS: 1US FAERS
417LeukopeniaFAERS: 1US FAERS
418Loose toothFAERS: 1US FAERS
419Lymphocyte percentage decreasedFAERS: 1US FAERS
420MalnutritionFAERS: 1US FAERS
421MeaslesFAERS: 1US FAERS
422Medial Tibial Stress SyndromeFAERS: 1US FAERS
423Medical device site injuryFAERS: 1US FAERS
424MeningiomaFAERS: 1US FAERS
425Metabolic acidosisFAERS: 1US FAERS
426MiliariaFAERS: 1US FAERS
427MonoplegiaFAERS: 1US FAERS
428MultimorbidityFAERS: 1US FAERS
429MyopathyFAERS: 1US FAERS
430MyositisFAERS: 1US FAERS
431Nail toxicityFAERS: 1US FAERS
432Neutrophil count decreasedFAERS: 1US FAERS
433Neutrophil percentage increasedFAERS: 1US FAERS
434Noninfective gingivitisFAERS: 1US FAERS
435Ocular discomfortFAERS: 1US FAERS
436Oncologic complicationFAERS: 1US FAERS
437Oral fungal infectionFAERS: 1US FAERS
438Oropharyngeal blisteringFAERS: 1US FAERS
439Orthostatic hypertensionFAERS: 1US FAERS
440OsteolysisFAERS: 1US FAERS
441Otitis MediaFAERS: 1US FAERS
442Oxygen consumption increasedFAERS: 1US FAERS
443Palmar erythemaFAERS: 1US FAERS
444Pancreatic carcinomaFAERS: 1US FAERS
445Paranasal sinus hypersecretionFAERS: 1US FAERS
446ParesisFAERS: 1US FAERS
447Pericardial effusionFAERS: 1US FAERS
448PeriodontitisFAERS: 1US FAERS
449Peripheral artery thrombosisFAERS: 1US FAERS
450Peripheral embolismFAERS: 1US FAERS
451PeritonitisFAERS: 1US FAERS
452Peritonsillar AbscessFAERS: 1US FAERS
453PetechiaeFAERS: 1US FAERS
454Pharyngeal swellingFAERS: 1US FAERS
455Poor quality sleepFAERS: 1US FAERS
456Post procedural infectionFAERS: 1US FAERS
457Procedural complicationFAERS: 1US FAERS
458Product dispensing errorFAERS: 1US FAERS
459Product use in unapproved indicationFAERS: 1US FAERS
460Protein total abnormalFAERS: 1US FAERS
461Protein total increasedFAERS: 1US FAERS
462Protein urine presentFAERS: 1US FAERS
463Pulmonary arterial hypertensionFAERS: 1US FAERS
464Pulmonary congestionFAERS: 1US FAERS
465Pulmonary sepsisFAERS: 1US FAERS
466PurpuraFAERS: 1US FAERS
467Pyoderma GangrenosumFAERS: 1US FAERS
468Pyogenic granulomaFAERS: 1US FAERS
469Radiation associated painFAERS: 1US FAERS
470Radiation injuryFAERS: 1US FAERS
471Radicular painFAERS: 1US FAERS
472Recall phenomenonFAERS: 1US FAERS
473Rectal abscessFAERS: 1US FAERS
474Refractory cancerFAERS: 1US FAERS
475Rehabilitation therapyFAERS: 1US FAERS
476Remission not achievedFAERS: 1US FAERS
477Resting TremorFAERS: 1US FAERS
478Retinal DetachmentFAERS: 1US FAERS
479Retro-orbital neoplasmFAERS: 1US FAERS
480Right Ventricular HypertrophyFAERS: 1US FAERS
481Saliva alteredFAERS: 1US FAERS
482SarcopeniaFAERS: 1US FAERS
483SciaticaFAERS: 1US FAERS
484Sinus headacheFAERS: 1US FAERS
485Sputum retentionFAERS: 1US FAERS
486Squamous cell carcinomaFAERS: 1US FAERS
487Stevens-Johnson SyndromeFAERS: 1US FAERS
488Subcutaneous AbscessFAERS: 1US FAERS
489Sudden deathFAERS: 1US FAERS
490SunburnFAERS: 1US FAERS
491Suture related complicationFAERS: 1US FAERS
492Terminal stateFAERS: 1US FAERS
493ThrombocytosisFAERS: 1US FAERS
494ThrombophlebitisFAERS: 1US FAERS
495Thyroid hormones decreasedFAERS: 1US FAERS
496Tongue eruptionFAERS: 1US FAERS
497Tooth ExtractionFAERS: 1US FAERS
498Tracheal fistulaFAERS: 1US FAERS
499TrichorrhexisFAERS: 1US FAERS
500TrismusFAERS: 1US FAERS
501Troponin increasedFAERS: 1US FAERS
502Unevaluable eventFAERS: 1US FAERS
503Unresponsive to stimuliFAERS: 1US FAERS
504Urinary IncontinenceFAERS: 1US FAERS
505Urinary hesitationFAERS: 1US FAERS
506Urine albumin/creatinine ratio increasedFAERS: 1US FAERS
507UrticariaFAERS: 1US FAERS
508Vascular stent insertionFAERS: 1US FAERS
509VertigoFAERS: 1US FAERS
510Vocal Cord ParalysisFAERS: 1US FAERS
511Vulvovaginal discomfortFAERS: 1US FAERS
512White blood cell count abnormalFAERS: 1US FAERS
513XerodermaFAERS: 1US FAERS
514treatment failureFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.